Effect of the irregular inner shape of a glass vessel on prednisone dissolution results

Dissolution Technologies

Volumn 12, Issue 4, 2005, Pages 15-19

  Tanaka, Makoto ^a   Fujiwara, Hiroyasu ^a   Fujiwara, Morimasa ^a  

^a Takao Manufacturing Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISONE;

ARTICLE; DRUG RELEASE; DRUG SOLUBILITY; GEOMETRY; GLASS VESSEL SHAPE; MEASUREMENT PRECISION; PHYSICAL PARAMETERS; REPRODUCIBILITY; TABLET DISINTEGRATION;

EID: 84962103849     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT120405P15     Document Type: Article

References (12)

1. Achanta, A, S., Gray, V. A., Cecil, T. L., Grady, L. T., "Evaluation of the performance of prednisone and salicylic acid USP dissolution calibrators," Drug Dev. Ind. Pharm., 21, 1171-1182, 1995.
2. Kaniwa, N., " Typical variability in dissolution testing and its qualification," Pharm. Tech. Japan, 18, 105-111, 2002.
3. Skoug, J. W., " Calibration of dissolution rate apparatuses: A User's Perspective," Dissolution Technologies, 1(2, Fall), 3-5, 1994.
4. Qureshi, S. A., McGilveray, I. J., "Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product," Eur. J. Pharm. Sci. 7, 249-258, 1999.
5. Gray, V. A., "Identifying source of error and variability in dissolution calibration and sample testing," American Pharmaceutical Review, Summer, 8, 2002.
6. Cox, D. C., Wells, C. E., Furman, W. B., Savage, T. S., King, A. C., "Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere," J. Pharm. Sci., 71, 395-399, 1982.
7. Scott, P., "Geometric Irregularities Common to the Dissolution Vessel," Dissolution Technologies, 12, (1, February), 18-21, 2005.
8. Kaniwa, N., Katori, N., Aoyagi, N., Ishigame, N., Seta, Y., Shinba, T., Fujiwara, K., Nakai, T., Oda, Y., Kojima, S., "Collaborative study on the development of a standard for evaluation of vibration levels for dissolution apparatus," Int. J. Pharm., 175, 119-129, 1998.
9. Aoyagi, N., Katori, N., Izutsu, K., Kojima, S., The 123rd Annual Meeting of Pharmaceutical Society of Japan, Nagasaki, March 27, 2003.
10. Yano, H., Yada, M., Ohya, M., Shigyo, M., Hamaura, T., Koike, A., Takahashi, H., Kusai, A., The 124th Annual Meeting of Pharmaceutical Society of Japan, Osaka, March 30, 2004.
11. Pharmacopeial Forum, 27, 3432-3439, 2001.
12. Qureshi, S. A., Shabnam, J., " Cause of high variability in drug dissolution testing and its impact on setting tolerances," Eur. J. Pharm. Sci., 12, 271-276, 2001.